| CYP11B2 (THB/TH-Aldo) diabetic men |
6.479 ± 1.299, n = 21 |
0.027 |
| CYP11B2 (THB/TH-Aldo) control men |
8.882 ± 0.5929, n = 155 |
|
| CYP11B2 (THB/TH-Aldo) diabetic women |
6.241 ± 1.042, n = 20 |
0.834 |
| CYP11B2 (THB/TH-Aldo) control women |
6.411 ± 0.3256, n = 161 |
|
| CYP11B2 (18-OH-THA/TH-Aldo) diabetic men |
4.808 ± 1.545, n = 21 |
0.541 |
| CYP11B2 (18-OH-THA/TH-Aldo) control men |
3.867 ± 0.4918, n = 155 |
|
| CYP11B2 (18-OH-THA/TH-Aldo) diabetic women |
5.607 ± 1.395, n = 20 |
0.144 |
| CYP11B2 (18-OH-THA/TH-Aldo) control women |
3.317 ± 0.3976, n = 161 |
|
| CYP11B1 (THS/cortisol) diabetic men |
1.176 ± 0.298, n = 21 |
<0.0001 |
| CYP11B1 (THS/cortisol) control men |
0.4697 ± 0.02239, n = 155 |
|
| CYP11B1 (THS/cortisol) diabetic women |
0.6595 ± 0.08961, n = 20 |
0.0595 |
| CYP11B1 (THS/cortisol) control women |
0.4829 ± 0.02434, n = 161 |
|
| HSD11B2 (F/E) diabetic men |
0.7214 ± 0.08597, n = 21 |
0.0004 |
| HSD11B2 (F/E) control men |
0.9214 ± 0.02052, n = 155 |
|
| HSD11B2 (F/E) diabetic women |
0.7795 ± 0.1299, n = 20 |
0.0002 |
| HSD11B2 (F/E) control women |
0.9215 ± 0.02232, n = 161 |
|
| Whole HSD11B (THF+5α-THF)/THE diabetic men |
1.119 ± 0.0709, n = 21 |
0.1504 |
| Whole HSD11B (THF+5α-THF)/THE control men |
1.663± 0.1720, n = 151 |
|
| Whole HSD11B (THF+5α-THF)/THE diabetic women |
1.141 ± 0.1458, n = 20 |
0.1396 |
| Whole HSD11B (THF+5α-THF)/THE control women |
2.071 ± 0.4288, n = 158 |
|
